Spears Abacus Advisors LLC Astrazeneca PLC Transaction History
Spears Abacus Advisors LLC
- $4.73 Billion
- Q3 2024
A detailed history of Spears Abacus Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 4,126 shares of AZN stock, worth $277,184. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,126
Previous 3,310
24.65%
Holding current value
$277,184
Previous $258,000
24.42%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...